In the realm of neurological disorders, epilepsy has long posed significant challenges due to its complex nature and the difficulty in managing its symptoms. Vigabatrin marks a significant advancement in the treatment of epilepsy, being the first “designer” drug specifically tailored to address the needs of patients resistant to conventional medications. Its development and mechanism […]
Martindale Pharma, a UK-based global pharmaceutical company, has successfully secured regulatory approval for its innovative clobazam oral suspension, branded as Epaclob and Silocalm, in seven European countries. This marks a significant expansion of the company’s product availability across the continent. Broad Regulatory Approval The regulatory approval encompasses France, Ireland, Germany, and Italy for Epaclob, and […]
